• Home
  • CML Experts
    • Team of experts on CML who developed imatinib>
      • Dr. Elisabeth Buchdunger
      • Dr. Brian Druker
      • Dr. John Goldman
      • Dr. Nora C. Heisterkamp
      • Dr. David Hungerford
      • Dr. Nicholas Lydon
      • Dr. Felix Mitelman
      • Dr. Peter C. Nowell
      • Dr. Carlo Gambacorti-Passerini
      • Dr. Moshe Talpaz
      • Dr. Janet D. Rowley
      • Dr. Charles Sawyers
      • Dr. Jürg Zimmermann
      • Dr. Owen Witte
    • Experts involved in developing nilotinib>
      • Dr. Frank Giles
    • Experts involved in developing dasatinib>
      • Dr. Jagabandhu Das
    • Other CML experts in America>
      • Other CML experts in Canada>
        • Dr. Sarit Assouline
        • Dr. Lambert Busque
        • Dr. Robert Delage
        • Dr. Josée Hébert
        • Dr. Pierre Laneuville
        • Dr. Jeffrey H Lipton
        • Dr. Luigina Mollica
      • Other CML experts in US>
        • Carolyn Blasdel, RN , FNP-BC, OCN
        • PATRICIA JAKEL, RN, MN, AOCN
        • Rey Garcia, RN, BSN
        • Dr. Jorge E. Cortes
        • Dr. Arul Chinnaiyan
        • Dr. Michael Deininger
        • Dr. James D. Griffin
        • Dr. Elias J. Jabbour
        • Dr. Hagop Kantarjian
        • Dr. Richard A. Larson
        • Dr. Alison Loren
        • Dr. Michael Mauro
        • Dr. Stephen D. Nimer
        • Dr. Ruben A. Mesa
        • Dr. Susan M. O'Brien
        • Dr. Jerald P. Radich
        • Dr. Karen Seiter
        • Dr. Neil Shah
        • Dr. Richard Stone
        • Dr. Raoul Tibes
        • Dr. Bin Zhang
    • Other CML Experts in Europe>
      • Dr. Jane Apperley
      • Dr. Michele Baccarani
      • Pr. Agnès Buzyn
      • Dr. Gabriel Etienne
      • Dr. François Guilhot
      • Dr. Eliane Gluckman
      • Dr. Andreas Hochhaus
      • Dr. Tessa L Holyoake
      • Dr. Hana Klamova
      • Dr. Jeroen J.W.M. Janssen
      • Dr. Franck-Emmanuel Nicolini
      • Dr. Delphine Rea
      • Dr. Johan Richter
      • Dr. Philippe Rousselot
      • Dr. Giuseppe Saglio
      • Dr. François-Xavier Mahon
    • Other CML experts in Asia>
      • Dr. Charles Chuah
      • Dr. Goh Yeow Tee
      • Dr. Pankaj Malhotra
      • Dr. Kim Dong-Wook
    • Other CML experts in Australia>
      • Dr. Susan Branford
      • Pr Tim Hughes
      • Dr. Anthony P Schwarer
  • Medical Concepts
    • Introduction to CML
    • Blood
    • DNA
    • Immune System>
      • Natural killer cell - NK
      • T Cells
    • JAK2 Gene
    • Polymerase Chain Reaction
    • Stem Cells
    • Donor lymphocyte infusion (DLI)
    • Myeloproliferative disorders (MPD)>
      • Chronic Myeloid Leukemia (CML)
      • Essential Thrombocythemia (ET)
      • Myelofibrosis (MF)
      • Polycythemia Vera (PV)
    • Types of leukemia
  • Medication
    • Hydroxyurea
    • Interferon Alpha
    • Gleevec (Imatinib)
    • Tasigna (Nilotinib)
    • Sprycel (Dasatinib)
    • (Bosutinib)
    • (Ponatinib)
    • Supect (Radotinib)
  • Managing side effects
    • List of side effets>
      • Bone Pain
      • Depression
      • Eyes
      • Ear
      • Fatigue
      • Fluid Retention
      • Gastrointestinal system
      • Hair
      • Heart
      • Kidney
      • Muscle cramping
      • Skin
    • Art Therapy>
      • Art Therapist
      • CMLer's portofolio
    • Massage therapy
    • Music therapy>
      • YouTube creation by CMLer's family
      • Magnificent (I Believe)
    • Physical Activity
    • Psycho-Oncology
    • Professionnel help and literature
    • Yoga
    • Zootherapy
  • Patient Testimonials
    • Gary Gonzales
    • Pat Elliott
    • Rob Shick
    • Virginia Garner
    • Laura Boyd
    • Drew Johnston
    • Royston Hogan
    • Doug Jenson
    • Rich Jones
    • Kevin Williams
    • Jan Geissler
    • Jean McGlynn
    • Tamera Simonson
    • Hans Loland
    • Christopher
    • Alexa Score
    • Others testimonials
    • Some celebrities>
      • Tim Holcomb
      • Doris Muramatsu
      • Ryan O'Neal
      • Kareem Abdul-Jabar
      • Jason Blake
      • Rick Upchurch
    • Bud Romine - the first patient
    • Kayla Naton (Pregnancy)
    • Suzan Mc Namara and the petition
  • Blogs
    • Trey's CML Leukemia Blog
    • Living with CML
    • CMKID's blog – Dislodging the bullet
    • CML Recovery - Stopping KTI
    • Hans's Blog
    • David's Blog
    • Elizabeth's Blog - my leukemia journey
    • Elizabeth's Blog - Heart of the rose
    • Donna C's Blog
    • Ian's Blog
    • Joe's Blog
    • Jon's Blog
    • Josh's Blog
    • Lisa's Blog
    • Matt's Blog
    • Matthew's Blog
    • Michelle's Blog
    • Michelle D's Blog
    • Nayree's Blog
    • Rob's Blog
  • News on CML (Chronic myeloid leukemia)
    • English
    • French (Français)
    • Spanish (Español)
  • Various topics
    • You’ve just been diagnosed
    • History of CML
    • CML causes
    • Food and Drug Interactions
    • Bone marrow transplant
    • Stem cells from umbilical cord blood
    • Children with CML
    • CML and pregnancy
    • Elderly patients with CML
    • Cure possible for CML?
    • CML vaccine
    • Feverfew extract (parthenolide)
    • Possible cure for CML in Fish Oil
    • Can dandelions kill cancer?
    • The French trial called STIM (Stop Imatinib)
    • Math could help cure leukemia
    • Mutation T315I
    • Sports with CML
    • CML Awareness Day
  • Congresses, conferences, meetings ASH, ASCO, EHA ...
    • ASCO 2012 - Chicago
    • ASCO 2011 - Chicago
    • ASCO 2010 - Chicago
    • ASH 2011 - San Diego
    • ASH 2010 - Orlando
    • ASH 2009 - New Orleans
    • BTG 2011 - Singapore (Singapore)
    • EHA 2011 - London (England)
    • EHA 2010 - Cascais (Portugal)
    • EHA 2009 - Berlin (Germany)
    • EHA 2008 - Copenhague (Danemark)
    • NHSM 2011 (Bergen, Norway)
    • NHSM 2010 (Uppsala, Sweden)
  • Moral Support
    • Family support
    • The march toward healing
    • Be happy
    • I Had Cancer: You are not alone
    • Where to get help and support
    • Dances at the Cancer Research Centre
    • Magnificent - Beauty of nature
  • Patient Rights
  • Links to other sites, forums and Facebook
    • Sites ( English and other languages)
    • Forums
    • CML on Facebook
    • CML on Twitter
    • Audio Podcast
  • Specialist Journals in Hematology/Oncology
  • International publications
    • Publications from Africa
    • Publications from America
    • Publications from Australia
    • Publications from Asia
    • Publications from Europe
  • Foundations
    • Leukemia Foundations>
      • American Cancer Society
    • Hospital Foundations
  • CML Glossaries
  • Educational events
  • Educational videos
    • Educational videos (in English)
    • Educación de vídeos en español (in Spanish)
    • Vidéos pédagogiques en français (in French)
  • About us
  • Guestbook
  • Comments

Chronic Myeloid Leukemia

 

Myelofibrosis (MF)

''Myelofibrosis is a serious bone marrow disorder that disrupts your body's normal production of blood cells. The result is extensive scarring in your bone marrow, leading to severe anemia, weakness, fatigue, and often, an enlarged spleen and liver.''
Definition by Mayo Clinic staff

Myelofibrosis 2012 Update - Mayo Clinic
March 12, 2012, Mayo Clinic

Drug Improves Quality of Life, Extends Survival for Myelofibrosis
March 9, 2012, MD Anderson Cancer Center

Dr. Mesa Discusses JAK Inhibitors for Myelofibrosis
March 2, 2012, OncLiveTV

Update on JAK Inhibitor — Spleen Volume  Reduction and OS - Serge Verstovsek, MD, PhD.
January  27, 2012, OncUViewTV

Pediatric Myelofibrosis
January 16, 2012, Medscape

Dr. Hugh-Jones Discusses the JAK2 Inhibitor SAR302503
December  13, 2011, OncLiveTV

FDA Approves Jakafi
November 16, 2011, Drugs.com

FDA Approves Ruxolitinib For Treatment of Intermediate and High Risk Myelofibrosis
November 16, 2011, Hematology.org

Myelofibrosis Research Update - Mayo Clinic
August 10. 2011, Mayo Clinic

Sonali Smith, MD: An Introduction to Myelofibrosis at ASCO 2011
July 17, 2011, vitaloptions

JAK Inhibitor Ruxolitinib COMFORT-II Trial Shows Positive Results
June 20, 2011, OncUViewTV

What Do Patients with Myelofibrosis Need  to Know?
June 3, 2011,  OncUViewTV 

Myelofibrosis - Mayo Clinic
May 10. 2011, Mayo Clinic

Myelofibrosis in 2011 - MayoClinic
January 25. 2011, Mayo Clinic

INC424 (INCB018424) An oral, Janus kinase (JAK) inhibitor selective for JAK1 and JAK2
2011, Novartis Oncology

CYT387: Potent Dual Inhibitor of JAK 1/2 in Phase I/II Clinical Development (YM BioSciences Inc.)
November 4, 2010,
ymbiosciences

Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
September 16, 2010, The New England Journal of Medicine

Myelofibrosis Treatment
September 15, 2010, Insidermedicine In Depth

New Drug Provides Rapid, Lasting Relief for Myelofibrosis Patients
September 15, 2010, mdandersonorg

Myelofibrosis Update - Dr. Ruben Mesa
May 17,2010, Mayo Clinic

ASH2009: JAK Inhibitor Shows Promise in Myelofibrosis December 2009, MedPage Today

Dr. Ruben Mesa discusses the symptoms, treatment and research being conducted for Myelofibrosis.
July 19, 2009, Mayo Clinic

.
.

VIDEO


VIDEO


VIDEO

VIDEO






VIDEO






DE
O

VIDEO



VIDEO


VIDEO


VIDEO


VIDEO
VIDEO
VIDEO


   


VIDEO



         



VIDEO


VIDEO


VIDEO


VIDEO


VIDEO





  
Disclaimer:
We accept no responsibility for and make no representations or warranties regarding the content of the
information presented. Access to and use of the information herein is entirely  at the risk of the  user.









Create a free website with Weebly